Effects of aqueous extracts of Aconitum carmichaeli, Rhizoma bolbostemmatis, Phytolacca acinosa, Panax notoginseng and Gekko swinhonis Güenther on Bel-7402 cells

World Journal of Gastroenterology

Volumn 13, Issue 19, 2007, Pages 2743-2746

  Yan, Zhu Chen ^a   Chen, Dan ^a   Wu, Xiong Zhi ^a   Xie, Guang Ru ^a   Ba, Yi ^a   Yan, Zhao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chinese herb; Cytotoxicity; Differentiation; Hepatocarcinoma; Proliferation

Indexed keywords

ACONITINE; ACONITUM CARMICHAELI EXTRACT; ALBUMIN; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BOLBOSTEMMATIS EXTRACT; CHINESE DRUG; GEKKO SWINHONIS EXTRACT; PANAX NOTOGINSENG EXTRACT; PHYTOLACCA ACINOSA EXTRACT; PLANT MEDICINAL PRODUCT; RETINOIC ACID; TRYPAN BLUE; UNCLASSIFIED DRUG; WARMING AND RELIEVING COLD PHLEGM;

ACONITUM; ACONITUM CARMICHAELI; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFICACY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GEKKO SWINHONIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MEDICINAL PLANT; NONHUMAN; PHYTOLACCA ACINOSA; PHYTOLACCACEAE; PROTEIN SECRETION; RADIOIMMUNOASSAY;

EID: 34250715790     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i19.2743     Document Type: Article

References (14)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997; 47:5-27
2. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S294-S308
3. Petraccia L, Onori P, Sferra B, Lucchetta MC, Liberati G, Grassi M, Gaudio E. MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications. Clin Ter 2003; 154: 325-335
4. Cheng SC, Zhou J, Xie Y. P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines. Cell Biol Int 2005; 29: 269-275
5. Chan TY, Tomlinson B, Tse IY, Chan JC, Chan WW, Critchley JA. Aconitine poisoning due to Chinese herbal medicines: a review. Vet Hum Toxicol 1994, 36: 452-455
6. Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatocellular carcinoma. Hepatogastroenterology 2003; 50: 242-249
7. Sell S. The role of determined stern-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol 1993; 37:189-201
8. Sirulnik LA, Stone RM. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease. Clin Adv Hematol Oncol 2005; 3: 391-397, 429
9. Tallmann MS. Curative therapeutic approaches to APL. Ann Hematol 2004; 83 Suppl. 1: S81-S82
10. Muto Y, Moriwaki H, Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. N Engl J Med 1999; 340:1046-1047
11. Okuno M, Kojima S, Moriwaki H. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives. J Gastroenterol Hepatol 2001; 16: 1329-1335
12. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52 Suppl 3: iii1-iii8
13. Wu X, Chen D, Xie GR. Effects of Gekko sulfated polysaccharide on the proliferation and differentiation of hepatic cancer cell line. Cell Biol Int 2006; 30: 659-664
14. Hui AM, Makuuchi M, Li X. Cell cycle regulators and human hepatocarcinogenesis. Hepatogastroenterology 1998; 45: 1635-1642